Imma Danés

642 total citations
43 papers, 456 citations indexed

About

Imma Danés is a scholar working on Pediatrics, Perinatology and Child Health, Toxicology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Imma Danés has authored 43 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pediatrics, Perinatology and Child Health, 8 papers in Toxicology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Imma Danés's work include Pharmaceutical studies and practices (18 papers), Pharmacovigilance and Adverse Drug Reactions (8 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Imma Danés is often cited by papers focused on Pharmaceutical studies and practices (18 papers), Pharmacovigilance and Adverse Drug Reactions (8 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Imma Danés collaborates with scholars based in Spain, United Kingdom and Italy. Imma Danés's co-authors include Antonio Vallano, Antònia Agustí, Cristina Aguilera, Consuelo Pedrós, G. García, J.M. Arnau, Xavier Vidal, Josep Arnau, Josep Maria Arnau and J. Bosch and has published in prestigious journals such as Frontiers in Pharmacology, British Journal of Clinical Pharmacology and Acta Paediatrica.

In The Last Decade

Imma Danés

36 papers receiving 429 citations

Peers

Imma Danés

TOXIC

PPCH

PHARM

Cristina Aguilera Spain

Hélène Théophile France

Alexandra Păcurariu Netherlands

J.M. Arnau Spain

Gianmario Candore Netherlands

PC Hannaford United Kingdom

Kristina Juhlin Sweden

Marie‐Christine Pérault‐Pochat France

Georgy Genov Netherlands

Eileen Wu United States

Cristina Aguilera Spain

Imma Danés

252 ×1.0

TOXIC

172 ×1.0

PPCH

106 ×0.9

84 ×0.9

62 ×1.1

PHARM

Citations per year, relative to Imma Danés Imma Danés (= 1×) peers Cristina Aguilera

Countries citing papers authored by Imma Danés

Since Specialization

Citations

This map shows the geographic impact of Imma Danés's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Imma Danés with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Imma Danés more than expected).

Fields of papers citing papers by Imma Danés

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Imma Danés. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Imma Danés. The network helps show where Imma Danés may publish in the future.

Co-authorship network of co-authors of Imma Danés

This figure shows the co-authorship network connecting the top 25 collaborators of Imma Danés. A scholar is included among the top collaborators of Imma Danés based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Imma Danés. Imma Danés is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Holko, Przemysław, Rafał Nowak, Marc Dooms, et al.. (2024). Clinical and non-clinical aspects of reimbursement policy for orphan drugs in selected European countries. Frontiers in Pharmacology. 15. 1498386–1498386. 2 indexed citations

Aguilera, Cristina, Imma Danés, Montserrat Bosch, et al.. (2022). Safety of Drugs Used during the First Wave of COVID-19: A Hospital-Registry-Based Study. Diagnostics. 12(7). 1612–1612. 2 indexed citations

Danés, Imma, et al.. (2022). Adverse Drug Reactions in Pediatric Oncohematology: A Systematic Review. Frontiers in Pharmacology. 12. 777498–777498. 4 indexed citations

Danés, Imma, Lourdes Vendrell, Laura Alonso, et al.. (2021). Adverse Reactions to Drugs of Special Interest in a Pediatric Oncohematology Service. Frontiers in Pharmacology. 12. 670945–670945. 4 indexed citations

Danés, Imma, Antònia Agustí, Antonio Vallano, et al.. (2014). Outcomes of off-label drug uses in hospitals: a multicentric prospective study. European Journal of Clinical Pharmacology. 70(11). 1385–1393. 19 indexed citations

Vallano, Antonio, Consuelo Pedrós, Antònia Agustí, et al.. (2010). Educational sessions in pharmacovigilance: What do the doctors think?. BMC Research Notes. 3(1). 311–311. 9 indexed citations

Agustí, Antònia, Consuelo Pedrós, Antonio Vallano, et al.. (2010). Effect of an intervention on the features of adverse drug reactions spontaneously reported in a hospital. European Journal of Clinical Pharmacology. 66(9). 937–945. 24 indexed citations

Ruíz‐Antorán, Belén, Antònia Agustí, Antonio Vallano, et al.. (2010). Use of non-specific intravenous human immunoglobulins in Spanish hospitals; need for a hospital protocol. European Journal of Clinical Pharmacology. 66(6). 633–641. 18 indexed citations

Pedrós, Consuelo, Antonio Vallano, Antònia Agustí, et al.. (2009). An Intervention to Improve Spontaneous Adverse Drug Reaction Reporting by Hospital Physicians. Drug Safety. 32(1). 77–83. 70 indexed citations

10.

Pandolfini, Chiara, Maurizio Bonati, Valentina Rossi, et al.. (2008). The DEC-net European register of paediatric drug therapy trials: contents and context. European Journal of Clinical Pharmacology. 64(6). 611–617. 7 indexed citations

11.

Jacqz-Aigrain, Évelyne, Chiara Pandolfini, Maurizio Bonati, et al.. (2006). Le registre européen des essais cliniques pédiatriques est une réalité. Therapies. 61(2). 121–124. 1 indexed citations

12.

Vallano, Antonio, G. García, Consuelo Pedrós, et al.. (2005). Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital. British Journal of Clinical Pharmacology. 60(6). 653–658. 178 indexed citations

13.

Vallano, Antonio, Imma Danés, & Carlos Ochoa Sangrador. (2004). Tratamiento antimicrobiano de las infecciones bronquiales en los servicios de urgencias hospitalarios. Anales de Pediatría. 61(2). 143–149. 7 indexed citations

14.

Danés, Imma & Montserrat Bosch. (2003). Cómo se puede prevenir y tratar la osteoporosis inducida por glucocorticoides. Medicina Clínica. 120(12). 473–475. 2 indexed citations

15.

Danés, Imma, et al.. (2002). [Drug utilization and recommended conditions for use in children].. PubMed. 57(5). 414–9.

16.

Danés, Imma & Josep Arnau. (2001). ¿Es segura la administración de quinolonas en la edad pediátrica?. Medicina Clínica. 117(17). 676–677.

17.

Danés, Imma, et al.. (2001). Nuevas pautas de antibioterapia en la faringoamigdalitis aguda. Medicina Clínica. 117(3). 115–116. 4 indexed citations

18.

Danés, Imma, et al.. (2001). Síndrome de hipersensibilidad por antiepilépticos. Medicina Clínica. 116(4). 155–156. 4 indexed citations

19.

Cobos, N., et al.. (2000). DNase use in the daily care of cystic fibrosis: who benefits from it and to what extent? Results of a cohort study of 199 patients in 13 centres. European Journal of Pediatrics. 159(3). 176–181. 20 indexed citations

20.

Danés, Imma & Antònia Agustí. (2000). Glucocorticoides inhalados y efectos sobre el crecimiento de los niños. Medicina Clínica. 114(13). 517–518.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact